# Endoscopic Biliary RFA of Malignant Bile Duct Obstruction

> **NCT02582541** · NA · UNKNOWN · sponsor: **The Second Hospital of Nanjing Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Cholangiocarcinoma
- Bile Duct Obstruction

## Interventions

- **PROCEDURE:** SEMS alone
- **PROCEDURE:** SEMS plus radiofrequency ablation

## Key facts

- **NCT ID:** NCT02582541
- **Lead sponsor:** The Second Hospital of Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2015-10
- **Final completion:** 2018-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582541, "Endoscopic Biliary RFA of Malignant Bile Duct Obstruction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02582541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*